In nasopharyngeal carcinoma, GDF10 is regulated downward due to its promoter's aberrant methylation, which can be reversed when treated with 5-Aza-2′-deoxycytidine. This evidence concerns the gene GDF10 and nasopharyngeal carcinoma.